Patheon Priced, NYSE: PTHN

Global provider of contract drug manufacturing and development services.

Industry: Health Care

Latest Trade: $34.96 0.00 (0.0%)

First Day Return: +19.0%

Return from IPO: +66.5%

Industry: Health Care

Patheon is a leading global provider of outsourced pharmaceutical development and manufacturing services. We provide a comprehensive, integrated and highly customizable range of active pharmaceutical ingredient, or API, and finished drug product services to our customers, from formulation development to clinical and commercial-scale manufacturing, packaging, and life cycle management. Our services address both small molecule and large molecule biological drugs. We believe we are the only end-to-end integrated provider of such services, which, combined with our scientific and regulatory expertise and specialized capabilities, allows our customers to partner with a single outsourced provider to address their most complex development and manufacturing needs. We believe we have the broadest technological capabilities in our industry, across the full spectrum of development and manufacturing, to support our end-to-end integrated platform.
more less
IPO News for Patheon
more
IPO Data
IPO File Date 06/08/2015
Offer Price $21.00
Price Range $19.00 - $22.00
Offer Shares (mm) 29.8
Deal Size ($mm) $625
IPO Data
IPO Date 07/20/2016
Offer Price $21.00
Price Range $19.00 - $22.00
Offer Shares (mm) 29.8
Deal Size ($mm) $625
Underwriters
more
Company Data
Headquarters Amsterdam, Netherlands
Founded 1974
Employees 8,800
Website www.patheon.com